4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-19-023478
President and CEO sold 18,333 shares at an average $25.03 ($458,800)
From the SEC's structured data for this filing
Trades in this filing
Watts Ryan J. · President and CEO
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-04-01 | Sale : show line 1 in the form | −6,050 | $23.91 | $144,656 | 2,609,921 | I |
| 2019-04-02 | Sale : show line 2 in the form | −3,200 | $24.52 | $78,464 | 2,606,721 | I |
| 2019-04-02 | Sale : show line 3 in the form | −2,942 | $25.17 | $74,050 | 2,603,779 | I |
| 2019-04-03 | Sale : show line 4 in the form | −5,641 | $26.28 | $148,245 | 2,598,138 | I |
| 2019-04-03 | Sale : show line 5 in the form | −500 | $26.77 | $13,385 | 2,597,638 | I |
| Open-market sales · 18,333 sh · avg $25.03 · $458,800 | ||||||
Loading xslF345X03/doc4.xml…